Witnessing the stock’s movement on the chart, on February 11, 2021, Collegium Pharmaceutical Inc. (NASDAQ: COLL) had a quiet start as it plunged -3.20% to $25.12. During the day, the stock rose to $26.08 and sunk to $24.17 before settling in for the price of $25.95 at the close. Taking a more long-term approach, COLL posted a 52-week range of $13.00-$26.91.
Meanwhile, its Annual Earning per share during the time was 5.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 42.80%. This publicly-traded company’s shares outstanding now amounts to $34.54 million, simultaneously with a float of $31.82 million. The organization now has a market capitalization sitting at $833.98 million. At the time of writing, stock’s 50-day Moving Average stood at $21.42, while the 200-day Moving Average is $19.66.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 255 employees. It has generated 1,163,533 per worker during the last fiscal year. Meanwhile, its income per employee was -89,106. The stock had 3.93 Receivables turnover and 0.99 Total Asset turnover. For the Profitability, stocks gross margin was +34.73, operating margin was -8.00 and Pretax Margin of -7.66.
Collegium Pharmaceutical Inc. (COLL) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. According to the most recent insider trade that took place on Jan 20, this organization’s EVP and General Counsel sold 6,081 shares at the rate of 24.45, making the entire transaction reach 148,680 in total value, affecting insider ownership by 103,582. Preceding that transaction, on Jan 15, Company’s EVP & Chief Commercial Officer sold 1,322 for 22.89, making the whole transaction’s value amount to 30,261. This particular insider is now the holder of 44,395 in total.
Collegium Pharmaceutical Inc. (COLL) Earnings and Revenue Records
As on 9/29/2020, Multinational firm has announced its last quarter scores, in which it reported $0.32 earnings per share (EPS) for the period falling under the consensus outlook (set at $0.33) by -$0.01. This company achieved a net margin of -7.66 while generating a return on equity of -25.39. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.3 per share during the current fiscal year.
Collegium Pharmaceutical Inc.’s EPS increase for this current 12-month fiscal period is 42.80% and is forecasted to reach 1.47 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 0.55% through the next 5 years, which can be compared against the 5.70% growth it accomplished over the previous five years trading on the market.
Collegium Pharmaceutical Inc. (NASDAQ: COLL) Trading Performance Indicators
Let’s observe the current performance indicators for Collegium Pharmaceutical Inc. (COLL). It’s Quick Ratio in the last reported quarter now stands at 1.00. The Stock has managed to achieve an average true range (ATR) of 1.46. Alongside those numbers, its PE Ratio stands at $50.34, and its Beta score is 1.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.71. Similarly, its price to free cash flow for trailing twelve months is now 10.17.
In the same vein, COLL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.50, a figure that is expected to reach 0.29 in the next quarter, and analysts are predicting that it will be 1.47 at the market close of one year from today.
Technical Analysis of Collegium Pharmaceutical Inc. (COLL)
Going through the that latest performance of [Collegium Pharmaceutical Inc., COLL]. Its last 5-days volume of 2.87 million indicated improvement to the volume of 0.84 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 76.07% While, its Average True Range was 1.50.
Raw Stochastic average of Collegium Pharmaceutical Inc. (COLL) in the period of the previous 100 days is set at 81.49%, which indicates a major rise in contrast to 62.79% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 54.80% that was higher than 45.31% volatility it exhibited in the past 100-days period.